The historical rank and industry rank for Emmaus Life Sciences's Net Margin % or its related term are showing as below:
EMMA'
s Net Margin % Range Over the Past 10 Years
Min: -8325.95 Med: -1351 Max: 5.84
Current: -16.66
EMMA's Net Margin % is ranked better than 68.84% of 1027
companies
in the Biotechnology industry
Industry Median: -162.58
vs EMMA: -16.66
Emmaus Life Sciences Net Margin % Historical Data
The historical data trend for Emmaus Life Sciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Emmaus Life Sciences's Net Margin %
For the Biotechnology subindustry, Emmaus Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emmaus Life Sciences's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Emmaus Life Sciences's Net Margin % falls into.
Emmaus Life Sciences Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Emmaus Life Sciences's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emmaus Life Sciences (OTCPK:EMMA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Emmaus Life Sciences Net Margin % Related Terms
Thank you for viewing the detailed overview of Emmaus Life Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Emmaus Life Sciences (Emmaus Life Sciences) Business Description
Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMMA has been successfully added to your 